(MENAFN- EIN Presswire) EINPresswire/ -- The global dry powder inhaler market is set to witness sustained growth over the forecast period, driven by the increasing prevalence of respiratory disorders, ...
Somerset Live on MSN
Somerset woman says she suffered severe asthma attack after blue inhalers phased out by NHS
She says the new medication is harder to use ...
The FDA has approved a generic form of fluticasone propionate inhalation aerosol (Flovent HFA) as a prophylactic maintenance treatment for asthma, the agency announced on Tuesday. Delivered as a ...
Key market opportunities in the inhaler solution market include the rising demand driven by increased respiratory disorders like asthma and COPD, expanding access to medicines in low and middle-income ...
As health systems seek to balance innovation with the need to address sustainability, increasing attention is being paid to ...
The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five ...
New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD ...
Dry Powder Inhalers: A Double Win for COPD and Environment By Dennis Thompson HealthDay ReporterTUESDAY, Feb. 24, 2026 (HealthDay News) — Dry powder inhalers might provide a double benefit for people ...
Add Yahoo as a preferred source to see more of our stories on Google. Children who use a lot of blue reliever inhalers are several times more likely to have severe asthma attacks [BBC] A new study is ...
Capital waiting to be deployed in the private equity market, or so-called dry powder, rose 8% to a record $2.59 trillion in the past year, S&P said Tuesday. S&P said the mountain of unused capital in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results